Modeling ATM mutant proteins from missense changes confirms retained kinase activity

Giancarlo Barone, Alix Groom, Anne Reiman, Venkataramanan Srinivasan, Philip J Byrd, A Malcolm R Taylor

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Ataxia-telangiectasia mutated (ATM) is the gene mutated in the cancer-predisposing disorder ataxia-telangiectasia (A-T). We modeled ATM sequence variants identified in UK A-T patients to determine the stability and kinase activity of the resulting proteins as well as the distribution of these mutations across the coding region. Of 20 missense changes modeled, 10 proteins showed ATM kinase activity and 10 showed none. In the majority of cases the mutant ATM protein was unstable, although this was variable. Reduction in ATM kinase activity can result either from the presence of low levels of unstable mutant protein with relatively normal specific kinase activity or from stable mutant protein with deficient ATM kinase activation. Indeed, ATM mutant proteins without kinase activity toward downstream targets were still able to autophosphorylate on serine 1981, although in a much less efficient manner, suggesting that this was not sufficient for ATM activation. In terms of function, green fluorescent protein (GFP)-tagged kinase inactive ATM proteins could form ionizing radiation (IR)-induced foci (IRIF), at least temporarily, which colocalized with the DNA double-strand break (DSB) marker gammaH2AX. Consistent with this, both kinase active and inactive mutant ATM proteins were able to interfere with phosphorylation of targets by endogenous ATM. Since the majority of missense mutations occurred C-terminal to aa1966, including all 10 mutations with absence of kinase activity, the implication was that mutations N-terminal to this, with exceptions, are less likely to result in loss of kinase activity and therefore, are less likely to be identified in A-T patients.

Original languageEnglish
Pages (from-to)1222-30
Number of pages9
JournalHuman Mutation
Volume30
Issue number8
DOIs
Publication statusPublished - Aug 2009

Fingerprint

Ataxia Telangiectasia Mutated Proteins
Ataxia Telangiectasia
Mutant Proteins
Phosphotransferases
Protein Kinases
Mutation
Double-Stranded DNA Breaks
Missense Mutation
Ionizing Radiation
Green Fluorescent Proteins
Serine
Phosphorylation

Keywords

  • Ataxia Telangiectasia Mutated Proteins
  • Blotting, Western
  • Cell Cycle Proteins
  • Cell Division
  • DNA Damage
  • DNA Repair
  • DNA-Binding Proteins
  • Enzyme Activation
  • G2 Phase
  • Humans
  • Infrared Rays
  • Mutation, Missense
  • Protein-Serine-Threonine Kinases
  • Tumor Suppressor Proteins
  • Journal Article
  • Research Support, Non-U.S. Gov't

Cite this

Barone, G., Groom, A., Reiman, A., Srinivasan, V., Byrd, P. J., & Taylor, A. M. R. (2009). Modeling ATM mutant proteins from missense changes confirms retained kinase activity. Human Mutation, 30(8), 1222-30. https://doi.org/10.1002/humu.21034

Modeling ATM mutant proteins from missense changes confirms retained kinase activity. / Barone, Giancarlo; Groom, Alix; Reiman, Anne; Srinivasan, Venkataramanan; Byrd, Philip J; Taylor, A Malcolm R.

In: Human Mutation, Vol. 30, No. 8, 08.2009, p. 1222-30.

Research output: Contribution to journalArticle

Barone, G, Groom, A, Reiman, A, Srinivasan, V, Byrd, PJ & Taylor, AMR 2009, 'Modeling ATM mutant proteins from missense changes confirms retained kinase activity' Human Mutation, vol. 30, no. 8, pp. 1222-30. https://doi.org/10.1002/humu.21034
Barone, Giancarlo ; Groom, Alix ; Reiman, Anne ; Srinivasan, Venkataramanan ; Byrd, Philip J ; Taylor, A Malcolm R. / Modeling ATM mutant proteins from missense changes confirms retained kinase activity. In: Human Mutation. 2009 ; Vol. 30, No. 8. pp. 1222-30.
@article{8a672710e0654fa28fa23ab6a2c09ca5,
title = "Modeling ATM mutant proteins from missense changes confirms retained kinase activity",
abstract = "Ataxia-telangiectasia mutated (ATM) is the gene mutated in the cancer-predisposing disorder ataxia-telangiectasia (A-T). We modeled ATM sequence variants identified in UK A-T patients to determine the stability and kinase activity of the resulting proteins as well as the distribution of these mutations across the coding region. Of 20 missense changes modeled, 10 proteins showed ATM kinase activity and 10 showed none. In the majority of cases the mutant ATM protein was unstable, although this was variable. Reduction in ATM kinase activity can result either from the presence of low levels of unstable mutant protein with relatively normal specific kinase activity or from stable mutant protein with deficient ATM kinase activation. Indeed, ATM mutant proteins without kinase activity toward downstream targets were still able to autophosphorylate on serine 1981, although in a much less efficient manner, suggesting that this was not sufficient for ATM activation. In terms of function, green fluorescent protein (GFP)-tagged kinase inactive ATM proteins could form ionizing radiation (IR)-induced foci (IRIF), at least temporarily, which colocalized with the DNA double-strand break (DSB) marker gammaH2AX. Consistent with this, both kinase active and inactive mutant ATM proteins were able to interfere with phosphorylation of targets by endogenous ATM. Since the majority of missense mutations occurred C-terminal to aa1966, including all 10 mutations with absence of kinase activity, the implication was that mutations N-terminal to this, with exceptions, are less likely to result in loss of kinase activity and therefore, are less likely to be identified in A-T patients.",
keywords = "Ataxia Telangiectasia Mutated Proteins, Blotting, Western, Cell Cycle Proteins, Cell Division, DNA Damage, DNA Repair, DNA-Binding Proteins, Enzyme Activation, G2 Phase, Humans, Infrared Rays, Mutation, Missense, Protein-Serine-Threonine Kinases, Tumor Suppressor Proteins, Journal Article, Research Support, Non-U.S. Gov't",
author = "Giancarlo Barone and Alix Groom and Anne Reiman and Venkataramanan Srinivasan and Byrd, {Philip J} and Taylor, {A Malcolm R}",
year = "2009",
month = "8",
doi = "10.1002/humu.21034",
language = "English",
volume = "30",
pages = "1222--30",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley",
number = "8",

}

TY - JOUR

T1 - Modeling ATM mutant proteins from missense changes confirms retained kinase activity

AU - Barone, Giancarlo

AU - Groom, Alix

AU - Reiman, Anne

AU - Srinivasan, Venkataramanan

AU - Byrd, Philip J

AU - Taylor, A Malcolm R

PY - 2009/8

Y1 - 2009/8

N2 - Ataxia-telangiectasia mutated (ATM) is the gene mutated in the cancer-predisposing disorder ataxia-telangiectasia (A-T). We modeled ATM sequence variants identified in UK A-T patients to determine the stability and kinase activity of the resulting proteins as well as the distribution of these mutations across the coding region. Of 20 missense changes modeled, 10 proteins showed ATM kinase activity and 10 showed none. In the majority of cases the mutant ATM protein was unstable, although this was variable. Reduction in ATM kinase activity can result either from the presence of low levels of unstable mutant protein with relatively normal specific kinase activity or from stable mutant protein with deficient ATM kinase activation. Indeed, ATM mutant proteins without kinase activity toward downstream targets were still able to autophosphorylate on serine 1981, although in a much less efficient manner, suggesting that this was not sufficient for ATM activation. In terms of function, green fluorescent protein (GFP)-tagged kinase inactive ATM proteins could form ionizing radiation (IR)-induced foci (IRIF), at least temporarily, which colocalized with the DNA double-strand break (DSB) marker gammaH2AX. Consistent with this, both kinase active and inactive mutant ATM proteins were able to interfere with phosphorylation of targets by endogenous ATM. Since the majority of missense mutations occurred C-terminal to aa1966, including all 10 mutations with absence of kinase activity, the implication was that mutations N-terminal to this, with exceptions, are less likely to result in loss of kinase activity and therefore, are less likely to be identified in A-T patients.

AB - Ataxia-telangiectasia mutated (ATM) is the gene mutated in the cancer-predisposing disorder ataxia-telangiectasia (A-T). We modeled ATM sequence variants identified in UK A-T patients to determine the stability and kinase activity of the resulting proteins as well as the distribution of these mutations across the coding region. Of 20 missense changes modeled, 10 proteins showed ATM kinase activity and 10 showed none. In the majority of cases the mutant ATM protein was unstable, although this was variable. Reduction in ATM kinase activity can result either from the presence of low levels of unstable mutant protein with relatively normal specific kinase activity or from stable mutant protein with deficient ATM kinase activation. Indeed, ATM mutant proteins without kinase activity toward downstream targets were still able to autophosphorylate on serine 1981, although in a much less efficient manner, suggesting that this was not sufficient for ATM activation. In terms of function, green fluorescent protein (GFP)-tagged kinase inactive ATM proteins could form ionizing radiation (IR)-induced foci (IRIF), at least temporarily, which colocalized with the DNA double-strand break (DSB) marker gammaH2AX. Consistent with this, both kinase active and inactive mutant ATM proteins were able to interfere with phosphorylation of targets by endogenous ATM. Since the majority of missense mutations occurred C-terminal to aa1966, including all 10 mutations with absence of kinase activity, the implication was that mutations N-terminal to this, with exceptions, are less likely to result in loss of kinase activity and therefore, are less likely to be identified in A-T patients.

KW - Ataxia Telangiectasia Mutated Proteins

KW - Blotting, Western

KW - Cell Cycle Proteins

KW - Cell Division

KW - DNA Damage

KW - DNA Repair

KW - DNA-Binding Proteins

KW - Enzyme Activation

KW - G2 Phase

KW - Humans

KW - Infrared Rays

KW - Mutation, Missense

KW - Protein-Serine-Threonine Kinases

KW - Tumor Suppressor Proteins

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1002/humu.21034

DO - 10.1002/humu.21034

M3 - Article

VL - 30

SP - 1222

EP - 1230

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 8

ER -